The DOI matches its Crossref record; 925 of the 925 references it cites were found in a registry or an index.
Targeting Metalloenzymes for Therapeutic Intervention
Open accessAbstract
Metalloenzymes are central to a wide range of essential biological activities, including nucleic acid modification, protein degradation, and many others. The role of metalloenzymes in these processes also makes them central for the progression of many diseases and, as such, makes metalloenzymes attractive targets for therapeutic intervention. Increasing awareness of the role metalloenzymes play in disease and their importance as a class of targets has amplified interest in the development of new strategies to develop inhibitors and ultimately useful drugs. In this Review, we provide a broad overview of several drug discovery efforts focused on metalloenzymes and attempt to map out the current landscape of high-value metalloenzyme targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–800 of 925
Arylamide Inhibitors of HIV-1 Integrase
Zhao, H., Neamati, N., Mazumder, A., Sunder, S., Pommier, Y. G., & Burke, T. R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960449w · Cited by 84
Persistence of Botulinum Neurotoxin A Subtypes 1-5 in Primary Rat Spinal Cord Cells
Whitemarsh, R. C. M., Tepp, W. H., Johnson, E. A., & Pellett, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090252 · Cited by 83
Bengamides Revisited: New Structures and Antitumor Studies
Thale, Z. I., Kinder, F. R. J., Bair, K. W., Bontempo, J., Czuchta, A. M., Versace, R. W., Phillips, P. E., Sanders, M. L., Wattanasin, S., & Crews, P. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo001380+ · Cited by 83
Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions
Moelling, K., Schulze, T., & Diringer, H. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5489-5491.1989 · Cited by 82
Inhibition of cell wall biosynthesis by analogues of alanine
Neuhaus, F. C., & Hammes, W. P. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90030-9 · Cited by 82
Structural analysis of neprilysin with various specific and potent inhibitors
Oefner, C., Roques, B. P., Fournie-Zaluski, M.-C., & Dale, G. E. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903027410 · Cited by 81
Inhibition of human arginase I by substrate and product analogues
Costanzo, L. D., Ilies, M., Thorn, K. J., & Christianson, D. W. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.02.004 · Cited by 81
A complex game of hide and seek: the search for new antifungals
Ngo, H., Garneau‐Tsodikova, S., & Green, K. D. (2016) · MedChemComm · doi:10.1039/c6md00222f · Cited by 81
High resolution crystal structure of the catalytic domain of MCR-1
Ma, G., Zhu, Y., Yu, Z., Ahmad, A., & Zhang, H. (2016) · Scientific Reports · doi:10.1038/srep39540 · Cited by 81
LpxC inhibitors: a patent review (2010-2016)
Kalinin, D. V., & Holl, R. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1360282 · Cited by 81
Evolution of the arginase fold and functional diversity
Dowling, D., Costanzo, L. D., Gennadios, H. A., & Christianson, D. W. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7554-z · Cited by 80
Xue, C., Voss, M. E., Nelson, D. J., Duan, J. J. ‐., Cherney, R. J., Jacobson, I. C., He, X., Roderick, J. J., Chen, L., Corbett, R. L., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010127e · Cited by 79
New tricks for human farnesyltransferase inhibitor: cancer and beyond
Wang, J., Yao, X., & Huang, J. Y. (2017) · MedChemComm · doi:10.1039/c7md00030h · Cited by 79
Chelator Fragment Libraries for Targeting Metalloproteinases
Agrawal, A., Johnson, S. L., Jacobsen, J. A., Miller, M. T., Chen, L., Pellecchia, M., & Cohen, S. M. (2010) · ChemMedChem · doi:10.1002/cmdc.200900516 · Cited by 78
Self-citationAnderson, M. S., Robertson, A. D., Macher, I., & Raetz, C. R. H. (1988) · Biochemistry · doi:10.1021/bi00406a017 · Cited by 78
Binding of α,α-Disubstituted Amino Acids to Arginase Suggests New Avenues for Inhibitor Design
Ilies, M., Costanzo, L. D., Dowling, D., Thorn, K. J., & Christianson, D. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200443b · Cited by 78
Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription
Champoux, J. J., & Schultz, S. J. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06909.x · Cited by 77
Eklund, H., Horjales, E., Vallée, B. L., & Jörnvall, H. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb13322.x · Cited by 77
Emerging trends in metalloprotein inhibition
Rouffet, M., & Cohen, S. M. (2011) · Dalton Transactions · doi:10.1039/c0dt01743d · Cited by 77
Self-citationShrestha, R. K., Ronau, J. A., Davies, C., Guenette, R. G., Strieter, E. R., Paul, L. N., & Das, C. (2014) · Biochemistry · doi:10.1021/bi5003162 · Cited by 77
Lai, X., Soler‐López, M., Wichers, H. J., & Dijkstra, B. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161697 · Cited by 77
The use of botanically derived agents for hyperpigmentation: A systematic review
Fisk, W. A., Agbai, O. N., Lev‐Tov, H. A., & Sivamani, R. K. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.048 · Cited by 76
Recent Progress in the Design of Small Molecule Inhibitors of HIV RNase H
Klumpp, K., & Mirzadegan, T. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873653 · Cited by 76
3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition
Patil, V., Sodji, Q. H., Kornacki, J. R., Mrksich, M., & Oyelere, A. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301769u · Cited by 75
Potent inhibitors of anthrax lethal factor from green tea
Dell’Aica, I., Donà, M., Tonello, F., Piris, A., Mock, M., Montecucco, C., & Garbisa, S. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400118 · Cited by 75
Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore
Marino, J. P., Fisher, P. W., Hofmann, G. A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061182w · Cited by 75
Metal-MACiE: a database of metals involved in biological catalysis
Andreini, C., Bertini, I., Cavallaro, G., Holliday, G. L., & Thornton, J. M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp256 · Cited by 75
Momparler, R. L., Côté, S., Momparler, L. F., & Idaghdour, Y. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-19 · Cited by 75
J. METHYLATION REACTIONS IN THE FORMATION AND METABOLISM OF CATECHOLAMINES AND OTHER BIOGENIC AMINES
Axelrod, J. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07245-x · Cited by 75
Binding of the Microbial Cyclic Tetrapeptide Trapoxin A to the Class I Histone Deacetylase HDAC8
Porter, N. J., & Christianson, D. W. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00330 · Cited by 74
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
Ma, Z., Liu, H., & Wu, B. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12169 · Cited by 73
Gunsior, M., Ravel, J., Challis, G. L., & Townsend, C. A. (2003) · Biochemistry · doi:10.1021/bi035762w · Cited by 73
Ye, Q.-Z., Xie, S.-X., Huang, M., Huang, W.-J., Lu, J.-P., & Ma, Z.-Q. (2004) · Journal of the American Chemical Society · doi:10.1021/ja045864p · Cited by 73
Padfield, P. L., & Morton, J. J. (1977) · Journal of Endocrinology · doi:10.1677/joe.0.0740251 · Cited by 73
Roxas-Duncan, V. I., Enyedy, I. J., Montgomery, V. A., Eccard, V. S., Carrington, M. A., Lai, H., Gul, N., Yang, D. C. H., & Smith, L. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00141-09 · Cited by 73
Yajima, S., Hara, K., Sanders, J. M., Yin, F., Ohsawa, K., Wiesner, J., Jomaa, H., & Oldfield, E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja040126m · Cited by 73
Metalloproteases from Pseudomonas aeruginosa Degrade Human RANTES, MCP-1, and ENA-78
Leidal, K. G., Munson, K. L., Johnson, M. C., & Denning, G. M. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003766628151 · Cited by 72
Park, J. G., Sill, P. C., Makiyi, E. F., García‐Sosa, A. T., Millard, C. B., Schmidt, J. J., & Pang, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.018 · Cited by 72
Borrmann, S., Adégnika, A. A., Moussavou, F., Oyakhirome, S., Esser, G., Matsiegui, P., Ramharter, M., Lundgren, I., Kombila, M., Issifou, S., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3749-3754.2005 · Cited by 72
Meinnel, T., & Blanquet, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.23.7737-7740.1993 · Cited by 72
Fala, L. (2015) · Europe PMC (PubMed Central) · Cited by 72
Structure of neprilysin in complex with the active metabolite of sacubitril
Schiering, N., D'Arcy, A., Villard, F., Ramage, P., Logel, C., Cumin, F., Ksander, G. M., Wiesmann, C., Karki, R. G., & Mogi, M. (2016) · Scientific Reports · doi:10.1038/srep27909 · Cited by 72
Krishnan, S., & Trievel, R. C. (2012) · Structure · doi:10.1016/j.str.2012.10.018 · Cited by 71
Rohdich, F., Bacher, A., & Eisenreich, W. (2004) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2004.05.012 · Cited by 71
HIV-1 RT-Associated RNase H Function Inhibitors: Recent Advances in Drug Development
Tramontano, E., & Santo, R. D. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792065045 · Cited by 71
Yoshizumi, A., Ishii, Y., Kimura, S., Saga, T., Harada, S., Yamaguchi, K., Kazuhiro, T., Livermore, D. M., Woodford, N., & Livermore, D. M. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0528-y · Cited by 71
Xue, J., Diao, J., Cai, G.-B., Deng, L., Zheng, B., Yao, Y., & Song, Y. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300419r · Cited by 71
A Novel Class of Herbicides (Specific Inhibitors of Imidazoleglycerol Phosphate Dehydratase)
Mori, I., Fonné‐Pfister, R., Matsunaga, S., Tada, S., Kimura, Y., Iwasaki, G., Mano, J., Hatano, M., Nakano, T., Koizumi, S., et al. (1995) · PLANT PHYSIOLOGY · doi:10.1104/pp.107.3.719 · Cited by 70
Tang, J. Y., Maddali, K., Dreis, C. D., Sham, Y. Y., Vince, R., Pommier, Y. G., & Wang, Z. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1002162 · Cited by 70
Reverse Fosmidomycin Derivatives against the Antimalarial Drug Target IspC (Dxr)
Behrendt, C., Kunfermann, A., Illarionova, V. A., Matheeussen, A., Pein‐Hackelbusch, M., Gräwert, T., Kaiser, J., Bacher, A., Eisenreich, W., Illarionov, B. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200694q · Cited by 70
Spectroscopic and Mechanistic Studies of Heterodimetallic Forms of Metallo-β-lactamase NDM-1
Yang, H., Aitha, M., Marts, A. R., Hetrick, A., Bennett, B., Crowder, M. W., & Tierney, D. L. (2014) · Journal of the American Chemical Society · doi:10.1021/ja410376s · Cited by 70
Hinchliffe, P., Tanner, C. A., Krismanich, A. P., Labbé, G., Goodfellow, V. J., Marrone, L., Desoky, A. Y., Calvopiña, K., Whittle, E. E., Zeng, F., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01299 · Cited by 69
Influenza virus–host interactomes as a basis for antiviral drug development
Watanabe, T., & Kawaoka, Y. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.08.008 · Cited by 68
Lo, T. W. C., & Thornalley, P. J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90680-h · Cited by 68
Plaumann, M., Pelzer-Reith, B., Martin, W. F., & Schnarrenberger, C. (1997) · Current Genetics · doi:10.1007/s002940050226 · Cited by 68
Yajima, S., Hara, K., Iino, D., Sasaki, Y., Kuzuyama, T., Ohsawa, K., & Seto, H. (2007) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309107024475 · Cited by 68
Synthesis and Antibacterial Activity of Peptide Deformylase Inhibitors
Huntington, K. M., Tian, Y., Wei, Y., & Pei, D. (2000) · Biochemistry · doi:10.1021/bi992452y · Cited by 68
Fragment-Based Identification of Influenza Endonuclease Inhibitors
Credille, C. V., Chen, Y., & Cohen, S. M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00628 · Cited by 68
Self-citationSluis‐Cremer, N., Arion, D., & Parniak, M. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.398 · Cited by 67
Gardelli, C., Nizi, E., Muraglia, E., Crescenzi, B., Ferrara, M., Orvieto, F., Pace, P., Pescatore, G., Poma, M., Ferreira, M. D. R. R., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0704705 · Cited by 67
Fullagar, J. L., Garner, A. L., Struss, A. K., Day, J. A., Martin, D. P., Yu, J., Cai, X., Janda, K. D., & Cohen, S. M. (2013) · Chemical Communications · doi:10.1039/c3cc41191e · Cited by 67
Self-citationDivalent metal ions control activity and inhibition of protein kinases
Knape, M. J., Ballez, M., Burghardt, N. C. G., Zimmermann, B., Bertinetti, D., Kornev, A. P., & Herberg, F. W. (2017) · Metallomics · doi:10.1039/c7mt00204a · Cited by 67
Kankanala, J., Kirby, K. A., Liu, F., Miller, L., Nagy, E., Wilson, D. J., Parniak, M. A., Sarafianos, S. G., & Wang, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00465 · Cited by 66
PA subunit of RNA polymerase as a promising target for anti-influenza virus agents
Nakazawa, M., Kadowaki, S.-E., Watanabe, I., Kadowaki, Y., Takei, M., & Fukuda, H. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.12.010 · Cited by 66
Deng, L., Diao, J., Chen, P., Pujari, V., Yao, Y., Cheng, G., Crick, D. C., Prasad, B. V. V., & Song, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200363d · Cited by 66
Structural Basis for the Design of Antibiotics Targeting Peptide Deformylase,
Hao, B., Gong, W., Rajagopalan, P. T. R., Zhou, Y., Pei, D., & Chan, M. K. (1999) · Biochemistry · doi:10.1021/bi982594c · Cited by 66
Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding
Skagseth, S., Akhter, S., Paulsen, M. H., Muhammad, Z., Lauksund, S., Samuelsen, Ø., Leiros, H. S., & Bayer, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.035 · Cited by 66
1,2,4‐Triazole‐3‐thione Compounds as Inhibitors of Dizinc Metallo‐β‐lactamases
Sevaille, L., Gavara, L., Bebrone, C., Luca, F. D., Nauton, L., Achard, M. E. S., Mercuri, P. S., Tanfoni, S., Borgianni, L., Guyon, C., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700186 · Cited by 66
Inhibitor Coordination Interactions in the Binuclear Manganese Cluster of Arginase,
Cama, E., Pèthe, S., Boucher, J., Han, S., Emig, F. A., Ash, D. E., Viola, R. E., Mansuy, D., & Christianson, D. W. (2004) · Biochemistry · doi:10.1021/bi0491705 · Cited by 65
Viral enzymes containing magnesium: Metal binding as a successful strategy in drug design
Rogolino, D., Carcelli, M., Sechi, M., & Neamati, N. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.07.006 · Cited by 65
Zinglé, C., Kuntz, L., Tritsch, D., Grosdemange‐Billiard, C., & Rohmer, M. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo9024732 · Cited by 65
Deng, L., Sundriyal, S., Rubio, V., Shi, Z.-Z., & Song, Y. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9012592 · Cited by 65
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.
Wang, J., Sheppard, G. S., Lou, P., Kawai, M., BaMaung, N. Y., Erickson, S., Tucker, L. A., Park, C. Y., Bouska, J. J., Wang, Y.-C., et al. (2003) · PubMed · Cited by 65
Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
Mouscadet, J. F., & Desmaële, D. (2010) · Molecules · doi:10.3390/molecules15053048 · Cited by 65
Christopeit, T., Carlsen, T. J. O., Helland, R., & Leiros, H. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01289 · Cited by 65
N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes
Carcelli, M., Rogolino, D., Gatti, A. M., Luca, L. D., Sechi, M., Kumar, G., White, S. W., Stevaert, A., & Naesens, L. M. J. (2016) · Scientific Reports · doi:10.1038/srep31500 · Cited by 64
Mode of inhibition of coformycin on adenosine deaminase.
SAWA, T., FUKAGAWA, Y., HOMMA, I., Takeuchi, T., & Umezawa, H. (1967) · PubMed · Cited by 63
ADAM10 Is the Major Sheddase Responsible for the Release of Membrane-associated Meprin A
Herzog, C., Haun, R. S., Ludwig, A., Shah, S. V., & Kaushal, G. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559088 · Cited by 63
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
Riederer, P., Gerlach, M., Müller, T., & Reichmann, H. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.06.015 · Cited by 63
Lerner, C., Masjost, B., Ruf, A., Gramlich, V., Jakob‐Roetne, R., Zürcher, G., Borroni, E., & Diederich, F. (2002) · Organic & Biomolecular Chemistry · doi:10.1039/b208690p · Cited by 63
2-Aminoimidazole Amino Acids as Inhibitors of the Binuclear Manganese Metalloenzyme Human Arginase I
Ilies, M., Costanzo, L. D., North, M. L., Scott, J. A., & Christianson, D. W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100306a · Cited by 63
Oefner, C., Douangamath, A., D'Arcy, A., Häfeli, S., Mareque, D., Sweeney, A. M., Padilla, J., Pierau, S., Schulz, H., Thormann, M., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00862-3 · Cited by 63
On the Relevance of the Met-turn Methionine in Metzincins
Tallant, C., García-Castellanos, R., Baumann, U., & Gomis‐Rüth, F. X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083378 · Cited by 63
Nara, H., Sato, K., Naito, T., Mototani, H., Oki, H., Yamamoto, Y., Kuno, H., Santou, T., Kanzaki, N., Terauchi, J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500981k · Cited by 63
Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1
Christopeit, T., Albert, A., & Leiros, H. S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.064 · Cited by 63
2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors
Haudecoeur, R., Carotti, M., Gouron, A., Maresca, M., Buitrago, E., Hardré, R., Bergantino, E., Jamet, H., Belle, C., Réglier, M., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00369 · Cited by 63
Zhang, F. L., & Casey, P. J. (1996) · Biochemical Journal · doi:10.1042/bj3200925 · Cited by 62
Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis.
Thabet, M. M., & Huizinga, T. W. J. (2006) · PubMed · Cited by 61
Fogal, S., Carotti, M., Giaretta, L., Lanciai, F., Nogara, L., Bubacco, L., & Bergantino, E. (2014) · Molecular Biotechnology · doi:10.1007/s12033-014-9800-y · Cited by 61
Light Chain of Botulinum Neurotoxin Serotype A: Structural Resolution of a Catalytic Intermediate,
Fu, Z., Chen, S., Baldwin, M. R., Boldt, G. E., Crawford, A., Janda, K. D., Barbieri, J. T., & Kim, J. P. (2006) · Biochemistry · doi:10.1021/bi060786z · Cited by 61
Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates
Thalhammer, A., Mecinović, J., Loenarz, C., Tumber, A., Rose, N. R., Heightman, T. D., & Schofield, C. J. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00592d · Cited by 60
Schiffmann, R., Heine, A., Klebe, G., & Klein, C. D. P. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500592 · Cited by 60
JONES, P. G., Altamura, S., Francesco, R. D., Paz, O. G., Kinzel, O. D., Mesiti, G., Monteagudo, E. S., Pescatore, G., Rowley, M., Verdirame, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800079s · Cited by 60
Capodagli, G. C., Sedhom, W. G., Jackson, M., Ahrendt, K. A., & Pegan, S. D. (2013) · Biochemistry · doi:10.1021/bi401022b · Cited by 59
Open Study of the Catechol-O-Methyltransferase Inhibitor Tolcapone in Major Depressive Disorder
D, M. F. M., Rosenbaum, J. F., Kolsky, A. R., Alpert, J. E., Nierenberg, A. A., Spillmann, M. K., Moore, C. M., Renshaw, P. F., Bottiglieri, T., Moroz, G., et al. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00008 · Cited by 59
Williams, P. D., Staas, D. D., Venkatraman, S., Loughran, H. M., Ruzek, R. D., Booth, T. M., Lyle, T. A., Wai, J. S. M., Vacca, J. P., Feuston, B. P., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.135 · Cited by 59
Семенова, Е. А., Johnson, A. A., Marchand, C., Davis, D. A., Yarchoan, R., & Pommier, Y. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020321 · Cited by 59
Angiotensin‐Converting Enzyme Inhibitors Side Effects—Physiologic and Non‐Physiologic Considerations
Sica, D. A. (2004) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2004.02866.x · Cited by 59
Falconer, S. B., Reid‐Yu, S. A., King, A. M., Gehrke, S. S., Wang, W., Britten, J. F., Coombes, B. K., Wright, G. D., & Brown, E. D. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00033 · Cited by 59
Liu, S., Jing, L., Yu, Z., Wu, C., Zheng, Y., Zhang, E., Chen, Q., Yu, Y., Guo, L., Wu, Y., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.032 · Cited by 59
Belleau, B., & Burba, J. V. (1961) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(61)90956-8 · Cited by 58
Design and Optimization of Tricyclic Phtalimide Analogues as Novel Inhibitors of HIV-1 Integrase
Verschueren, W. G., Dierynck, I., Amssoms, K., Hu, L., Boonants, P. M. J. G., Pille, G. M. E., Daeyaert, F. F. D., Hertogs, K., Surleraux, D. L. N. G., & Wigerinck, P. B. T. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049559q · Cited by 58
A Bioinorganic Approach to Fragment-Based Drug Discovery Targeting Metalloenzymes
Cohen, S. M. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00242 · Cited by 58
Self-citationSellin, S., Eriksson, L. E., Aronsson, A.-C., & Mannervik, B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32886-2 · Cited by 57
Harrison, S. T., Poslusney, M. S., Mulhearn, J. J., Zhao, Z., Kett, N. R., Schubert, J. W., Melamed, J. Y., Allison, T. J., Patel, S. B., Sanders, J. M., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500502d · Cited by 57
NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability
Hajduk, P. J., Shuker, S. B., Nettesheim, D. G., Craig, R., Augeri, D. J., Betebenner, D. A., Albert, D. H., Guo, Y. P., Meadows, R. P., Xu, L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020160g · Cited by 57
Probing chelation motifs in HIV integrase inhibitors
Agrawal, A., DeSoto, J., Fullagar, J. L., Maddali, K., Rostami, S., Richman, D. D., Pommier, Y. G., & Cohen, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112389109 · Cited by 57
Self-citationStructure–activity relationships of the thujaplicins for inhibition of human tyrosinase
Yoshimori, A., Oyama, T., Takahashi, S., Abe, H., Kamiya, T., Abe, T., & Tanuma, S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.027 · Cited by 57
IK682, a tight binding inhibitor of TACE
Niu, X., Umland, S. P., Ingram, R. N., Beyer, B. M., Liu, Y., Sun, J., Lundell, D. J., & Orth, P. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.034 · Cited by 57
Zhang, Y., Hegen, M., Xu, J. Y., Keith, J. C., Jin, G., Du, X., Cummons, T. A., Sheppard, B. J., Sun, L., Zhu, Y., et al. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.08.003 · Cited by 57
Natural Products in the Chemical Industry
Schaefer, B. (2014) · Springer eBooks · doi:10.1007/978-3-642-54461-3 · Cited by 57
Mizrahi, V., Usdin, M. T., Harington, A., & Dudding, L. R. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.18.5359 · Cited by 56
Structure and Activity of Human Mitochondrial Peptide Deformylase, a Novel Cancer Target
Escobar-Alvarez, S., Goldgur, Y., Yang, G., Ouerfelli, O., Li, Y., & Scheinberg, D. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.02.032 · Cited by 55
Il-Park, S., & Walsh, C. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9210 · Cited by 55
Peptide Deformylase: A New Target in Antibacterial, Antimalarial and Anticancer Drug Discovery
Sangshetti, J. N., Khan, F. A. K., & Shinde, D. B. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826115734 · Cited by 55
Erlandsen, H., Flatmark, T., Stevens, R. C., et al. (1998) · Biochemistry · doi:10.1021/bi9815290 · Cited by 55
Shen, M., Pan, P., Li, Y., Li, D., Yu, H., & Hou, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.002 · Cited by 54
Aráoz, R., Anhalt, E., René, L., Badet‐Denisot, M., Courvalin, P. M., & Badet, B. (2000) · Biochemistry · doi:10.1021/bi001408b · Cited by 54
Zhu, J., Cai, X., Harris, T., Gooyit, M., Wood, M. R., Lardy, M. A., & Janda, K. D. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.03.012 · Cited by 54
Sakaki, H., Okada, M., Kuramoto, K., Takeda, H., Watarai, H., Suzuki, S., Seino, S., Seino, M., Ohta, T., Nagase, S., et al. (2015) · PubMed · Cited by 54
Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.
Johnson, D. A., Carter-Hamm, B., & Dralle, W. M. (1982) · PubMed · doi:10.1164/arrd.1982.126.6.1070 · Cited by 53
Structural definitions of Jumonji family demethylase selectivity
Pilka, E. S., James, T., & Lisztwan, J. H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.013 · Cited by 53
A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer
Dumez, H., Gall, H., Capdeville, R., Dutreix, C., van Oosterom, A. T., & Giaccone, G. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328010ef5b · Cited by 52
Structural basis of catalysis by monometalated methionine aminopeptidase
Ye, Q.-Z., Xie, S.-X., Ma, Z.-Q., Huang, M., & Hanzlik, R. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602433103 · Cited by 52
Johnson, J. W., Gretes, M. C., Goodfellow, V. J., Marrone, L., Heynen, M., Strynadka, N. C. J., & Dmitrienko, G. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9086374 · Cited by 52
Specificity for inhibitors of metal-substituted methionine aminopeptidase
Li, J.-Y., Chen, L., Cui, Y.-M., Luo, Q., Li, J. X., Nan, F.-J., & Ye, Q.-Z. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01144-6 · Cited by 52
Salaspuro, M. P., Lindros, K. O., & Pikkarainen, P. H. (1978) · Metabolism · doi:10.1016/0026-0495(78)90001-x · Cited by 52
Acute Liver Injury due to Flavocoxid (Limbrel), a Medical Food for Osteoarthritis
Chalasani, N., Vuppalanchi, R., Navarro, V., Fontana, R., Bonkovsky, H., Barnhart, H., Kleiner, D. E., Hoofnagle, J. H., & on behalf of the Drug-Induced Liver Injury Network (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00006 · Cited by 52
Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides
Hang, J. Q., Rajendran, S., Yang, Y., Li, Y., Wong-Kai-In, P., Overton, H. A., Parkes, K. E. B., Cammack, N., Martin, J. A., & Klumpp, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.061 · Cited by 52
Design of Amino Acid Aldehydes as Transition-State Analogue Inhibitors of Arginase
Shin, H., Cama, E., & Christianson, D. W. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047788w · Cited by 51
Qian, M., Bai, S. A., Brogdon, B. L., Wu, J., Liu, R., Covington, M. B., Vaddi, K., Newton, R. C., Fossler, M. J., Garner, C. E., et al. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015933 · Cited by 51
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates
Levin, J. I., Chen, J. M., Cheung, K., Cole, D. C., Crago, C. F., Santos, E. D., Du, X., Khafizova, G., MacEwan, G., Niu, C., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00514-6 · Cited by 51
Wang, X., Gao, P., Menéndez‐Arias, L., Liu, X., & Zhan, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170113110839 · Cited by 51
Clayton, G. M., Klein, D. J., Rickert, K. W., Patel, S. B., Kornienko, M. A., Zugay-Murphy, J., Reid, J. C., Tummala, S., Sharma, S. P., Singh, S. B., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.513028 · Cited by 50
Tratamiento antigripal: fármacos actualmente utilizados y nuevos agentes en desarrollo
Amarelle, L., Lecuona, E., & Sznajder, J. I. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2016.07.004 · Cited by 50
Design of Amino Acid Sulfonamides as Transition-State Analogue Inhibitors of Arginase
Cama, E., Shin, H., & Christianson, D. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036365b · Cited by 50
Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I
Takasawa, R., Saeki, K., Tao, A., Yoshimori, A., Uchiro, H., Fujiwara, M., & Tanuma, S. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.012 · Cited by 49
Moali, C., Brollo, M., Custot, J., Sari, M., Boucher, J., Stuehr, D. J., & Mansuy, D. (2000) · Biochemistry · doi:10.1021/bi992992v · Cited by 49
A Photoreactive Small-Molecule Probe for 2-Oxoglutarate Oxygenases
Rotili, D., Altun, M., Kawamura, A., Wolf, A., Fischer, R., Leung, I. K. H., Mackeen, M. M., Tian, Y.-M., Ratcliffe, P. J., Mai, A., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.007 · Cited by 49
Tang, J. Y., Liu, F., Nagy, E., Miller, L., Kirby, K. A., Wilson, D. J., Wu, B., Sarafianos, S. G., Parniak, M. A., & Wang, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01879 · Cited by 49
Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain
Caglič, D., Krutein, M. C., Bompiani, K. M., Barlow, D. J., Benoni, G., Pelletier, J. C., Reitz, A. B., Lairson, L. L., Houseknecht, K. L., Smith, G. R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4012164 · Cited by 49
Crouch, N. P., Adlington, R. M., Baldwin, J. E., Lee, M. H., & MacKinnon, C. H. (1997) · Tetrahedron · doi:10.1016/s0040-4020(97)00398-0 · Cited by 48
Kawamura, S., Unno, Y., List, A., Mizuno, A., Tanaka, M., Sasaki, T., Arisawa, M., Asai, A., Groll, M., & Shuto, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4002296 · Cited by 48
Garrabrant, T. A., Tuman, R. W., Ludovici, D. W., Tominovich, R. M., Simoneaux, R., Galemmo, R. A., & Johnson, D. L. (2004) · Angiogenesis · doi:10.1007/s10456-004-6089-7 · Cited by 48
Haudecoeur, R., Gouron, A., Dubois, C., Jamet, H., Lightbody, M., Hardré, R., Milet, A., Bergantino, E., Bubacco, L., Belle, C., et al. (2014) · ChemBioChem · doi:10.1002/cbic.201402003 · Cited by 48
Design and synthesis of potent Gram-negative specific LpxC inhibitors
Mansoor, U. F., Vitharana, D., Reddy, P. A., Daubaras, D. L., McNicholas, P. M., Orth, P., Black, T. A., & Siddiqui, M. A. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.111 · Cited by 47
Inhibitor Discovery of Full-Length New Delhi Metallo-β-Lactamase-1 (NDM-1)
Shen, B., Yu, Y., Chen, H., Cao, X., Lao, X., Fang, Y., Shi, Y. Y., Chen, J., & Zheng, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062955 · Cited by 47
Recent clinical trials with omapatrilat: New developments
Zanchi, A., Maillard, M. P., & Burnier, M. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0045-6 · Cited by 47
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
Lian, T., Jiang, X., & Jing, Z. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s117277 · Cited by 47
Tarhonskaya, H., Nowak, R. P., Johansson, C., Szykowska, A., Tumber, A., Hancock, R. L., Lang, P. A., Flashman, E., Oppermann, U. C. T., Schofield, C. J., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.08.007 · Cited by 47
Chofor, R., Sooriyaarachchi, S., Risseeuw, M., Bergfors, T., Pouyez, J., Johny, C., Haymond, A. N., Everaert, A., Dowd, C. S., Maes, L. J. R. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5014264 · Cited by 46
Wang, W.-L., Chai, S. C., Huang, M., He, H.-Z., Hurley, T. D., & Ye, Q.-Z. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8005788 · Cited by 46
Identification of genes important for growth of asymptomatic bacteriuria Escherichia coli in urine
Vejborg, R. M., de Evgrafov, M. C. R., Phan, M., Totsika, M., Schembri, M. A., & Hancock, V. (2012) · QUT ePrints (Queensland University of Technology) · Cited by 46
Pang, Y., Vummenthala, A., Mishra, R. K., Park, J. G., Wang, S., Davis, J., Millard, C. B., & Schmidt, J. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007730 · Cited by 46
Kunfermann, A., Lienau, C., Illarionov, B. A., Held, J., Gräwert, T., Behrendt, C., Werner, P., Hähn, S., Eisenreich, W., Riederer, U., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012559 · Cited by 46
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
Cain, R. M., Brem, J., Zollman, D., McDonough, M. A., Johnson, R. M., SPENCER, J. M., Makena, A., Abboud, M. I., Cahill, S. T., Lee, S. Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01728 · Cited by 46
Ott, G. R., Asakawa, N., Lu, Z., Anand, R., Liu, R., Covington, M. B., Vaddi, K. G., Qian, M., Newton, R. C., Christ, D. D., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.075 · Cited by 45
Wu, Z., & Walsh, C. T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11603 · Cited by 45
Crystal Structure of Tryptophan Hydroxylase with Bound Amino Acid Substrate
Windahl, M. S., Petersen, C. R., Christensen, H. E. M., & Harris, P. (2008) · Biochemistry · doi:10.1021/bi8015263 · Cited by 45
Desvergne, A., Génin, E., Maréchal, X., Gallastegui, N., Dufau, L., Richy, N., Groll, M., Vidal, J., & Reboud‐Ravaux, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4002007 · Cited by 45
Cristalli, G., Vittori, S., Eleuteri, A., Volpini, R., Camaioni, E., Lupidi, G., Mahmood, N., Bevilacqua, F., & Palù, G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00020a017 · Cited by 45
Sharkey, E. M., O’Neill, H., Kavarana, M. J., Wang, H., Creighton, D. J., Sentz, D. L., & Eiseman, J. L. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800000130 · Cited by 44
Métifiot, M., Maddali, K., Johnson, B. C., Hare, S., Smith, S. J., Zhao, X. Z., Marchand, C., Burke, T. R., Hughes, S. H., Cherepanov, P., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300471n · Cited by 44
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes
Deng, L., Endo, K., Kato, M., Cheng, G., Yajima, S., & Song, Y. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100243r · Cited by 44
Targeting HIV-1 integrase with strand transfer inhibitors
Li, Y., Xuan, S., Feng, Y., & Yan, A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.001 · Cited by 44
Inhibition of monkey liver alcohol dehydrogenase by 4-methylpyrazole
MAKAR, A. B., & Tephly, T. R. (1975) · Biochemical Medicine · doi:10.1016/0006-2944(75)90172-6 · Cited by 44
Crystal Structure of Class I Acetohydroxy Acid Isomeroreductase from Pseudomonas aeruginosa
Ahn, H. J., Eom, S. J., Yoon, H., Lee, B. I., Cho, H., & Suh, S. W. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00264-x · Cited by 44
Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design
Kalinin, D. V., & Holl, R. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160413135835 · Cited by 44
Ellermann, M., Jakob‐Roetne, R., Lerner, C., Borroni, E., Schlatter, D., Roth, D., Ehler, A., Rudolph, M. G., & Diederich, F. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904410 · Cited by 43
Kuhn, N. J., Ward, S., Piponski, M., & Young, T. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1338 · Cited by 43
Lim, H., Cai, D., Archer, C. T., & Kodadek, T. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075469+ · Cited by 43
5-Lipoxygenase inhibitors: a review of recent patents (2010 – 2012)
Hofmann, B., & Steinhilber, D. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.791678 · Cited by 43
Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis
Moorthy, N. S. H. N., Sousa, S. F., Ramos, M. J., & Fernandes, P. A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113206660262 · Cited by 43
Akif, M., Schwager, S. L. U., Anthony, C. S., Czarny, B., Beau, F., Dive, V., Sturrock, E. D., & Acharya, K. R. (2011) · Biochemical Journal · doi:10.1042/bj20102123 · Cited by 43
Huguet, F., Melet, A., de Sousa, R. A., Lieutaud, A., Chevalier, J., Maigre, L., Deschamps, P., Tomas, A., Leulliot, N., Pagès, J., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200076 · Cited by 42
Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide
Iwai, Y., Takahashi, H., Hatakeyama, D., Motoshima, K., Ishikawa, M., Sugita, K., Hashimoto, Y., Harada, Y., Itamura, S., Odagiri, T., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.035 · Cited by 42
Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reaction
Gołȩbiowski, A., Whitehouse, D. L., Beckett, R. P., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.092 · Cited by 42
Tarrago‐Litvak, L., Andréola, M., Fournier, M., Nevinsky, G. A., Parissi, V., de Soultrait, V. R., & Litvak, S. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612024607162 · Cited by 42
Advances in Bacterial Methionine Aminopeptidase Inhibition
Helgren, T. R., Wangtrakuldee, P., Staker, B. L., & Hagen, T. J. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150813145410 · Cited by 42
Polyketides with New Delhi Metallo-β-lactamase 1 Inhibitory Activity from Penicillium sp.
Gan, M., Liu, Y., Bai, Y., Guan, Y., Li, L., Gao, R., He, W., You, X., Li, Y., Yu, L., et al. (2013) · Journal of Natural Products · doi:10.1021/np4000944 · Cited by 42
Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release
Daniel, K. B., Sullivan, E. D., Chen, Y., Chan, J. C., Jennings, P. A., Fierke, C. A., & Cohen, S. M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00539 · Cited by 42
Self-citationSantucci, M., Spyrakis, F., Cross, S., Quotadamo, A., Farina, D. S. F., Tondi, D., Luca, F. D., Docquier, J., Prieto, A. I., Ibacache‐Quiroga, C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17399-7 · Cited by 42
Mechanism and inhibition of 1-deoxy-d-xylulose-5-phosphate reductoisomerase
Murkin, A. S., Manning, K. A., & Kholodar, S. A. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.06.001 · Cited by 41
A Five-coordinate Metal Center in Co(II)-substituted VanX
Breece, R. M., Costello, A. L., Bennett, B., Sigdel, T. K., Matthews, M. L., Tierney, D. L., & Crowder, M. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412582200 · Cited by 41
Himmel, D. M., Myshakina, N. S., Ilina, T. V., Ry, A. V., Ho, W. C., Parniak, M. A., & Arnold, E. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.006 · Cited by 41
Bremer, P. T., Adler, M., Phung, C. H., Singh, A. K., & Janda, K. D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01393 · Cited by 41
3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2
Sheppard, G. S., Wang, J., Kawai, M., BaMaung, N. Y., Craig, R. A., Erickson, S. A., Lynch, L., Patel, J. R., Yang, F., Searle, X. B., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.031 · Cited by 40
Sova, M., Čadež, G., Turk, S., Majce, V., Polanc, S., Batson, S., Lloyd, A. J., Roper, D. I., Fishwick, C. W. G., & Gobec, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.034 · Cited by 40
Probing the Specificity Determinants of Amino Acid Recognition by Arginase
Shishova, E. Y., Costanzo, L. D., Emig, F. A., Ash, D. E., & Christianson, D. W. (2008) · Biochemistry · doi:10.1021/bi801911v · Cited by 40
Peptide deformylase: a target for novel antibiotics?
Pei, D. (2001) · Emerging Therapeutic Targets · doi:10.1517/14728222.5.1.23 · Cited by 40
Friedman, S., Levy, R., Garrett, W. M., Doval, D., Bondarde, S. A., Sahoo, T., Lokanatha, D., Julka, P. K., Shenoy, K., Nagarkar, R. V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-5056 · Cited by 40
Barankiewicz, J., Danks, A. M., Abushanab, E., Makings, L., Wiemann, T., Wallis, R. A., Pragnacharyulu, P. V. P., Fox, A. W., & Marangos, P. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37137-x · Cited by 40
Metal Ions Play an Essential Catalytic Role in the Mechanism of Ketol–Acid Reductoisomerase
Tadrowski, S., Pedroso, M. M., Sieber, V., Larrabee, J. A., Guddat, L. W., & Schenk, G. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201600620 · Cited by 40
Anti-Influenza Treatment: Drugs Currently Used and Under Development
Amarelle, L., Lecuona, E., & Sznajder, J. I. (2016) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2016.11.020 · Cited by 40
Hassounah, S. A., Alikhani, A., Oliveira, M., Bharaj, S., Ibanescu, R.-I., Osman, N., Xu, H.-T., Brenner, B. G., Mesplède, T., & Wainberg, M. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-17 · Cited by 40
Troubled Waters: The Future of Global Fisheries
Gewin, V. L. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020113 · Cited by 39
Garner, A. L., Struss, A. K., Fullagar, J. L., Agrawal, A., Moreno, A. Y., Cohen, S. M., & Janda, K. D. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300128f · Cited by 39
Self-citationCatalysis and Inhibition of Mycobacterium tuberculosis Methionine Aminopeptidase
Lu, J.-P., Chai, S. C., & Ye, Q.-Z. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901624n · Cited by 39
Pegan, S. D., Rukseree, K., Franzblau, S. G., & Mesecar, A. D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.003 · Cited by 39
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201901778 · Cited by 601
Cong, Y., Yang, S., & Rao, X. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2019.10.005 · Cited by 527
Chaudhary, D., Chong, F., Neupane, T., Choi, J., & Jee, J.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413661 · Cited by 14
Metadata
- Authors
- Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-09-07
- Volume
- 119
- Issue
- 2
- Pages
- 1323-1455
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2889619860
- Cited by
- 270
- References
- 925
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.